![]() |
市场调查报告书
商品编码
1744624
2032 年中央药房自动化市场预测:按产品、供应商类型、产能、技术、应用和地区进行的全球分析Central Fill Pharmacy Automation Market Forecasts to 2032 - Global Analysis By Offering (Equipment, Software, Services, and Other Service Types), Vendor Type, Capacity, Technology, Application, and By Geography |
根据 Stratistics MRC 的数据,全球中央配药药局自动化市场预计在 2025 年达到 7.508 亿美元,预测期内的复合年增长率为 13.3%,到 2032 年达到 17.9943 亿美元。
集中配药自动化是指利用先进技术和机器人系统简化集中药局的处方笺执行流程。该系统能够为多家零售药局和门诊药局批量处方笺,提高效率,减少用药错误,并加速配送速度。配药、包装和贴标等任务的自动化可以优化工作流程,最大限度地降低人事费用,并提高药品业务的准确性。
处方笺量增加
中央药房自动化有助于提高效率并减少人为错误,从而简化业务。对更快、更精准的配药解决方案的需求日益增长,推动了对自动化系统的投资。此外,加强药品安全性和最大程度减少配药错误的监管压力也推动了自动化系统的采用。药房越来越多地寻求扩充性的解决方案,以应对处方笺增长的处方量。因此,自动化技术正成为现代药局业务的重要组成部分。
小型药局的采用有限
由于成本限制和基础设施有限,小型药局在采用中央配药自动化系统时往往面临挑战。许多独立药局的营运预算有限,难以进行大规模的技术投资。将自动化系统整合到现有工作流程中也存在复杂性,这也可能成为一大障碍。此外,对业务中断和员工适应能力的担忧也阻碍了其快速采用。小型药局老闆的认知度有限以及对变革的抗拒也阻碍了采用。
扩大零售连锁药局
大型零售药局连锁店的扩张为中央配药自动化的实施提供了绝佳机会。大型药局零售商正在加大对自动化的投资,以优化效率并降低人事费用。标准化流程和集中式配药模式使零售连锁店能够实现更高的准确性和速度。此外,自动化有助于在多个地点保持一致性,从而确保统一的服务品质。随着处方笺配药需求的不断增长,大型药局连锁店正在实施自动化以简化业务。
资料安全和隐私问题
网路威胁和资料外洩风险是药局采用自动化技术面临的重大挑战。未授权存取敏感医疗资讯可能导致违规和法律责任。此外,对资料完整性和系统漏洞的担忧也是采用自动化技术的一大障碍。药局必须确保强大的安全通讯协定,以保护病患记录并维护信任。保护数位健康数据是企业面临的关键挑战。
COVID-19的影响
由于处方笺需求上升和业务限制,COVID-19 疫情加速了药房自动化的普及。封锁和保持社交距离的措施凸显了简化药局工作流程的必要性。自动化成为减少人际接触并维持高效处方笺处理的关键解决方案。药局越来越多地采用集中式模式来安全管理激增的处方笺。疫情过后,随着药局逐渐适应新的业务规范,我们预期自动化领域的投资将持续成长。
预计软体领域将成为预测期内最大的领域
软体领域预计将在预测期内占据最大的市场占有率,因为它在优化工作流程效率方面发挥关键作用。先进的药房管理系统能够与自动配药解决方案无缝整合。库存追踪、处方验证和患者资料管理等功能可提高业务效率。对云端基础平台的日益关注,进一步推动了药局自动化软体的采用。
预计医院药房部门在预测期内的复合年增长率最高。
由于对高效药物管理系统的需求日益增长,医院药局部门预计将在预测期内实现最高成长率。医院需要自动化解决方案来处理大量处方笺并确保及时配药。医院药房自动化整合可提高工作流程的准确性,并最大限度地减少用药错误。日益增长的患者入院人数和复杂的治疗方法需要先进的自动化系统来确保营运的平稳进行。
由于医疗保健行业的快速扩张和製药行业的蓬勃发展,预计亚太地区将在预测期内占据最大的市场占有率。政府推动医疗保健数位化和自动化的倡议正在推动该地区市场的扩张。慢性病负担的加重导致处方笺量增加,从而催生了对高效配药解决方案的需求。医疗基础设施和药房自动化投资的不断增加,进一步推动了市场的成长。
预计北美地区在预测期内的复合年增长率最高。这得归功于其先进的医疗基础设施和强有力的法律规范,这些框架支持自动化技术的采用。大型连锁药局和医疗保健提供者的出现正在加速对自动化系统的投资。不断上涨的医疗成本促使药局采用以效率为导向的解决方案,例如中央配药自动化。对处方笺准确性和病人安全性日益增长的需求也进一步推动了自动化技术的采用率。
According to Stratistics MRC, the Global Central Fill Pharmacy Automation Market is accounted for $750.80 million in 2025 and is expected to reach $1799.43 million by 2032 growing at a CAGR of 13.3% during the forecast period. Central Fill Pharmacy Automation refers to the use of advanced technologies and robotic systems to streamline the prescription fulfilment process at centralized pharmacy locations. This system enables bulk processing of prescriptions for multiple retail or outpatient pharmacies, improving efficiency, reducing medication errors, and ensuring faster delivery. By automating tasks such as dispensing, packaging, and labelling, it enhances workflow, minimizes labour costs, and supports higher accuracy in pharmaceutical operations.
Rising prescription volume
Central fill pharmacy automation helps streamline operations by improving efficiency and reducing manual errors. The growing demand for faster and accurate dispensing solutions is fuelling investment in automated systems. Additionally, regulatory pressure to enhance medication safety and minimize dispensing errors is boosting adoption. Pharmacies are increasingly seeking scalable solutions to accommodate higher prescription loads. As a result, automation technologies are becoming essential for modern pharmacy operations.
Limited adoption in small pharmacies
Smaller pharmacies often face challenges in adopting central fill automation due to cost constraints and infrastructure limitations. Many independent pharmacies operate with limited budgets, making significant technological investments difficult. The complexity of integrating automation with existing workflows can be another barrier. Additionally, concerns over operational disruption and workforce adaptation hinder rapid adoption. Limited awareness and resistance to change among smaller pharmacy owners also slow down implementation.
Growing retail chain pharmacies
The expansion of large retail pharmacy chains presents a significant opportunity for central fill automation adoption. Major pharmacy retailers are increasingly investing in automation to optimize efficiency and reduce labour costs. Standardized processes and centralized dispensing models enable retail chains to achieve higher accuracy and speed. Moreover, automation helps maintain consistency across multiple locations, ensuring uniform service quality. As the demand for prescription fulfilment grows, large pharmacy chains are adopting automation to streamline operations.
Data security and privacy concerns
The risk of cyber threats and data breaches poses a significant concern for pharmacies adopting automation. Unauthorized access to sensitive medical information can lead to compliance violations and legal liabilities. Additionally, concerns over data integrity and system vulnerabilities can deter adoption. Pharmacies must ensure robust security protocols to protect patient records and maintain trust. Safeguarding digital health data is a significant challenge for the company.
Covid-19 Impact
The COVID-19 pandemic accelerated the adoption of automation in pharmacies due to rising prescription demand and operational constraints. Lockdowns and social distancing measures highlighted the need for streamlined pharmacy workflows. Automation became a key solution to reduce human contact while maintaining efficient prescription fulfilments. Pharmacies increasingly turned to centralized models to manage surging prescription volumes safely. Post-pandemic, continued investment in automation is expected as pharmacies adapt to new operational norms.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, due to its critical role in optimizing workflow efficiency. Advanced pharmacy management systems enable seamless integration with automated dispensing solutions. Features such as inventory tracking, prescription verification, and patient data management enhance operational effectiveness. The rising focus on cloud-based platforms is further driving software adoption in pharmacy automation.
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospital pharmacies segment is predicted to witness the highest growth rate, due to the increasing need for efficient medication management systems. Hospitals require automated solutions to handle high prescription volumes and ensure timely dispensing. The integration of automation in hospital pharmacies enhances workflow accuracy and minimizes medication errors. Rising patient admissions and complex treatment regimens necessitate advanced automation systems for smooth operations.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare sector and growing pharmaceutical industry. Government initiatives promoting healthcare digitization and automation are driving market expansion in the region. The rising burden of chronic diseases is leading to higher prescription volumes, necessitating efficient dispensing solutions. Increasing investments in healthcare infrastructure and pharmacy automation are further boosting market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure and strong regulatory framework supporting automation adoption. The presence of leading pharmacy chains and healthcare providers is accelerating investment in automated systems. Rising healthcare costs are pushing pharmacies to adopt efficiency-driven solutions such as central fill automation. The growing demand for prescription accuracy and patient safety is further propelling adoption rates.
Key players in the market
Some of the key players profiled in the Central Fill Pharmacy Automation Market include Omnicell, ARxIUM, ScriptPro, RxSafe, Capsa Healthcare, McKesson Corporation, Swisslog Healthcare, Parata Systems, Innovation Associates, KUKA AG, Becton, Dickinson and Company (BD), Cornerstone Automation Systems, LLC (CASI), Tension Packaging & Automation, R/X Automation Solutions, and Yuyama Co., Ltd.
In May 2025, Omnicell, Inc. announced new products designed to streamline workflows and enhance inventory visibility and management in perioperative and clinic settings. These products, which leverage RFID tracking and intelligent software workflows, expand Omnicell's connected platform that is intended to automate medication management processes and deliver intelligent insights to drive clinical and operational outcomes across all settings of care.
In May 2025, Capsa Healthcare announced that Houston, TX-based Harris Health has chosen Capsa as its design and installation partner for a new automated central fill prescription processing solution. The partnership will significantly advance Harris Health's medication delivery capabilities for the health system's nearly 10,000 employees and more than 250,000 patients.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.